Meghan McGarry

Meghan McGarry

UNVERIFIED PROFILE

Are you Meghan McGarry?   Register this Author

Register author
Meghan McGarry

Meghan McGarry

Publications by authors named "Meghan McGarry"

Are you Meghan McGarry?   Register this Author

11Publications

169Reads

45Profile Views

Regional variations in longitudinal pulmonary function: A comparison of Hispanic and non-Hispanic subjects with cystic fibrosis in the United States.

Pediatr Pulmonol 2019 Sep 29;54(9):1382-1390. Epub 2019 May 29.

Department of Pediatrics, University of California, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ppul.24377DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702095PMC
September 2019

An admixture mapping meta-analysis implicates genetic variation at 18q21 with asthma susceptibility in Latinos.

J Allergy Clin Immunol 2019 Mar 7;143(3):957-969. Epub 2018 Sep 7.

Program in Pharmaceutical Sciences and Pharmacogenomics, University of California, San Francisco, San Francisco, Calif; Department of Bioengineering & Therapeutic Sciences, University of California, San Francisco, San Francisco, Calif; Department of Medicine, University of California, San Francisco, San Francisco, Calif.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00916749183127
Publisher Site
http://dx.doi.org/10.1016/j.jaci.2016.08.057DOI Listing
March 2019

Pulmonary function disparities exist and persist in Hispanic patients with cystic fibrosis: A longitudinal analysis.

Pediatr Pulmonol 2017 Dec 30;52(12):1550-1557. Epub 2017 Oct 30.

Department of Pediatrics, University of California, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ppul.23884DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693693PMC
December 2017

In vivo and in vitro ivacaftor response in cystic fibrosis patients with residual CFTR function: N-of-1 studies.

Pediatr Pulmonol 2017 04 9;52(4):472-479. Epub 2017 Jan 9.

Pediatric Pulmonology, Department of Pediatrics, University of California, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ppul.23659DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461115PMC
April 2017

Minorities Are Underrepresented in Clinical Trials of Pharmaceutical Agents for Cystic Fibrosis.

Ann Am Thorac Soc 2016 10;13(10):1721-1725

2 Department of Pediatrics, Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1513/AnnalsATS.201603-192BCDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122490PMC
October 2016

Normalization of sweat chloride concentration and clinical improvement with ivacaftor in a patient with cystic fibrosis with mutation S549N.

Chest 2013 Oct;144(4):e1-e4

Department of Pediatrics, University of California, San Francisco, San Francisco, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.13-0239DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502741PMC
October 2013